O. Bleijerveld

Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis

G. Pasterkamp, S. Sze, I. Hoefer, 2013, Proteomics. Clinical applications.

Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets.

A. Scholten, A. Heck, P. D. de Groot, 2014, Cardiovascular research.

Deep proteome profiling of circulating granulocytes reveals bactericidal/permeability-increasing protein as a biomarker for severe atherosclerotic coronary stenosis.

Elizabeth A. McClellan, Henk W. P. van den Toorn, Salvatore Cappadona, 2012, Journal of proteome research.

Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells

A. Scholten, A. Heck, W. Kolch, 2013, Leukemia.

High Precision Platelet Releasate Definition by Quantitative Reversed Protein Profiling—Brief Report

Mark Roest, A. Scholten, A. Heck, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Metabolipidomics: profiling metabolism of glycerophospholipid species by stable isotopic precursors and tandem mass spectrometry.

M. Houweling, Michael J. Thomas, Zheng Cui, 2006, Analytical biochemistry.

Targeted Phosphotyrosine Profiling of Glycoprotein VI Signaling Implicates Oligophrenin-1 in Platelet Filopodia Formation

A. Scholten, A. Heck, P. D. de Groot, 2013, Arteriosclerosis, thrombosis, and vascular biology.